Is CDKL5 p.Gly17= (c.51G>A) pathogenic?

CDKL5 p.Gly17= (c.51G>A) is classified Likely benign in CDKL5 (ClinVar, Single submitter, 1 submitter; last evaluated 2025-10-16). Very rare (popmax 0.00436%, amr); Associated with developmental and epileptic encephalopathy, 2.

What condition is associated with CDKL5 p.Gly17= (c.51G>A)?

CDKL5 p.Gly17= (c.51G>A) is associated with developmental and epileptic encephalopathy, 2 (ClinVar).

How common is CDKL5 p.Gly17= (c.51G>A) in the general population?

CDKL5 p.Gly17= (c.51G>A) is very rare (popmax 0.00436%, amr) (gnomAD).

How is CDKL5-deficiency disorder inherited?

Typically X-linked dominant (Orphanet). A genetic counselor can assess individual risk for a family.

CDKL5 p.Gly17=

c.51G>A · rs772299455 · VCV2068569

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Rare

very rare (popmax 0.00436%, amr)

Conditions

developmental and epileptic encephalopathy, 2

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal.
Splicing
SpliceAI	Δ0.26	donor loss · deltas
Constraint at this position
Conservation	phyloP 8.5	GERP 0.95, phastCons 1
Overall
CADD	11.88	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00436% Admixed American · 2/45,886 alleles

Filtering AF 0.000723% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00027%

Overall 0.000555% 6/1,081,866 alleles · very rare

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.00436%	22,943
Remaining individualsnot grpmax-eligible	0.00212%	47,125
European (non-Finnish)	0.000341%	293,549

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CDKL5
Protein: p.Gly17=
Coding: c.51G>A
MANE Select: NM_001323289
dbSNP: rs772299455
Type: single nucleotide variant
Location: chrX:18507147 (GRCh38)
Structure: AlphaFold pLDDT 53.76 · 3 PDB
Residue 17: the protein kinase domain; a β-strand

Full CDKL5 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

developmental and epileptic encephalopathy, 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For CDKL5-deficiency disorder (Orphanet):

Inheritance: X-linked dominant
Onset: Infancy, Neonatal

Similar variants

CDKL5 c.146-1G>A Pathogenic ★★★ same condition
CDKL5 p.Ala157Pro Likely pathogenic ★★★ same condition
CDKL5 p.Ala157Val Likely pathogenic ★★★ same condition
CDKL5 p.Ala40Val Pathogenic ★★★ same condition
CDKL5 p.Arg178Gln Pathogenic ★★★ same condition
CDKL5 p.Arg717= Likely pathogenic ★★★ same condition
CDKL5 p.Arg948Ter Pathogenic ★★★ same condition
CDKL5 p.Asp193Gly Likely pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkl5-p-gly17 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown